NFKB1 and Parkinson disease: Other small synthetic molecules and naturally derived compounds (see Table 4), such as juglanin, KHG26377, calycosin, isobavachalcone, diosgenin, and α-mangostin reportedly exert anti-inflammatory effects by inhibiting the NF-κB pathway in multiple PD models (153–158).